1. RUNX1 Loss of Function Drives Resistance to Lenalidomide in Del(5Q) Myelodysplastic Syndrome Patients. (April 2017) Authors: Martinez-Høyer, S.; Mo, A.; Docking, R.; Li, J.; Chan, S.; Umlandt, P.; Fuller, M.; Jädersten, M.; Hellström-Lindberg, E.; Platzbecker, U.; Parker, J.; Karsan, A. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗